Hybrid Imaging Modalities for the Evaluation of Infection
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The synergistic value of the fusion of physiologic and anatomical data has been described using several co-registration techniques for various nuclear medicine procedures and morphologic imaging modalities (single photon emission computed tomography-computed tomography [SPECT-CT], SPECT-magnetic resonance imaging [MRI], camera-based positron emission tomography [PET]-CT and PET-CT). The researchers hypothesize that fusion of nuclear medicine (NM) and CT data acquired sequentially in a single imaging session on one device is clinically superior to side-by-side evaluation of separately performed imaging tests. They hypothesize that more accurate localization of increased radiotracer activity on NM procedures will improve the diagnostic accuracy for detection of infection and will subsequently have a significant impact on patient management.
The purpose of the present study is to assess the clinical value of this new technology of fused imaging in patients undergoing diagnostic nuclear medicine evaluation for suspicion of an infection process.
| Condition | Intervention |
|---|---|
|
Infectious Diseases |
Device: Imaging |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | Nuclear Medicine for the Evaluation of Infection-the Added Value of Hybrid Imaging Modalities |
- The impact of the imaging modality on patient management [ Time Frame: 3 years ] [ Designated as safety issue: No ]
- The impact of the imaging modality on patient management [ Time Frame: 2 years ] [ Designated as safety issue: No ]
| Enrollment: | 300 |
| Study Start Date: | February 2006 |
| Study Completion Date: | March 2009 |
| Primary Completion Date: | April 2007 (Final data collection date for primary outcome measure) |
The researchers hypothesize that fusion of nuclear medicine (NM) and CT data acquired sequentially in a single imaging session on one device is clinically superior to side-by-side evaluation of separately performed imaging tests. They hypothesize that more accurate localization of increased radiotracer activity on NM procedures will improve the diagnostic accuracy for detection of infection and will subsequently have a significant impact on patient management.
The purpose of the present study is to assess the clinical value of this new technology of fused imaging in patients undergoing diagnostic nuclear medicine evaluation for suspicion of an infection process.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients referred for NM imaging procedures to assess the presence of infectious processes.
- Patients signed informed consent
Exclusion Criteria:
- The study will not be performed in pregnant or lactating women.
- Patients unable or unwilling to tolerate the scan until its completion
Contacts and Locations More Information
No publications provided
| Responsible Party: | Rambam Health Care Campus |
| ClinicalTrials.gov Identifier: | NCT00230152 History of Changes |
| Other Study ID Numbers: | infectionCTIL |
| Study First Received: | September 29, 2005 |
| Last Updated: | October 21, 2010 |
| Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
Additional relevant MeSH terms:
|
Communicable Diseases Infection |
ClinicalTrials.gov processed this record on May 16, 2013